Enzypep
Geleen
About Enzypep
Enzypep designs and develops oligopeptides for pharmaceutical products. The Enzypep technology is expected to become the state-of-the-art in design and preparation of complex peptides. Compared with standard synthesis it results in pharmaceutical products with a much higher purity, at a much lower cost and in a sustainable, environmentally-friendly manner. It began operation in 2012, with its headquarters in Geleen in the Netherlands.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Undisclosed (Jan 2014)
- Website: enzypep.com
- Phone: +31 (0)46 47 60 675
Industries & Categories
Biotechnology, Genetics, Health Care, Life Science, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/enzypep-2451827 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.